Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 6.64MCash and Equivalents
VS
Market
Sector
Industry
History
$ 2.52Close
$ 2 - $ 29.07 52-Week Range
Ticker Information
Ticker
BBLGCompany Name
BONE BIOLOGICS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQBONE BIOLOGICS CORP - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBLG - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 6/30/2025 | $ 6.64M |
| 3/31/2025 | $ 2.75M |
| 12/31/2024 | $ 3.33M |
| 9/30/2024 | $ 3.57M |
| 6/30/2024 | $ 2.33M |
| 3/31/2024 | $ 3.23M |
| 12/31/2023 | $ 3.03M |
| 9/30/2023 | $ 4.45M |
| 6/30/2023 | $ 7.01M |
| 3/31/2023 | $ 6.19M |
Key Performance Insights, Last 5 Years
- BONE BIOLOGICS CORP's latest trailing twelve months (TTM) CashnEq stands at $ 0.
- Over the past 5 years, BONE BIOLOGICS CORP's average CashnEq has been $ 3.85M.
- The median CashnEq for BONE BIOLOGICS CORP during this period was $ 3.57M
- BONE BIOLOGICS CORP reached its highest CashnEq over the past 5 years at $ 7.54M.
- The lowest CashnEq recorded by BONE BIOLOGICS CORP in the same timeframe $ 0
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.BBLG - Cash and Equivalents, Last 5 years
$ 0
Minimum
Dec 31, 2020
$ 7.54M
Maximum
Dec 31, 2022
$ 3.85M
Average
$ 3.57M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 99.33M with a standard deviation of $ 119.9M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.61K |
|---|---|
| min | $ 0 |
| max | $ 495M |
| average | $ 99.33M |
| median | $ 48.36M |
| std | $ 119.9M |